Allergy and Autoimmunity Diagnostics Driven to Advance Laboratory Science

Our mission is to enable our customers to make the world healthier, cleaner, and safer.

As the global leader in allergy and autoimmune disease diagnostics, we are committed to providing accurate, clinically relevant testing solutions to aid in the proper disease diagnosis and patient management.

 


Innovation 

We are the partner of choice for pushing the boundaries of innovation to overcome the uncertainty in allergy and autoimmune testing, and have a history of:

  • Being at the forefront of immunodiagnostics for more than 50 years, introducing an industry-shaping technology every decade.

 

 
  • Developing 55 new or improved, highly accurate tests to support the diagnosis of allergy and autoimmune diseases in the last five years alone. 
  • Growing a robust future pipeline to support the diagnosis of allergy and autoimmune diseases.
  • Updating and improving software in response to rapidly changing customer needs to maximize efficiencies.

Quality

We have established processes for innovation focused on quality and continuous improvement that enables us to:1

  • Provide clinically relevant, accurate tests for allergic and autoimmune disease, putting the patient first.
  • Leverage state-of-the-art technology to develop precise antigen reagents resulting in highly accurate tests with excellent lot-to-lot quality.
  • Develop software to maximize efficiencies, including remote instrument support, stock management, and automatic ordering.
  • Invest every year in numerous scientific study partnerships, research consortia, scientific symposia, and education materials.

 

Service

We provide an extensive service offering that delivers the support you need.

 

Efficient
  • Fully automated and scalable Phadia Laboratory Systems with automation track connectivity. 
  • Phadia™ Prime and Phadia™ LabCommunity™ software that supports lean operations and system maintenance. 
Reliable
  • Dedicated research and development and manufacturing facilities certified to ISO 13485:2016.
  • Outstanding supplier standards ensuring high-quality products are delivered on time and in full.

Collaborative
  • Dedicated application laboratory for support with discrepant results. 
  • World-class clinical and laboratory training and support, including enhanced clinical insights beyond just results.
  • Ongoing collaboration with the academic and scientific community around the globe.

ImmunoCAP™ Specific IgE Tests

Worldwide gold standard in in vitro allergy diagnostics2 designed to aid providers in the diagnosis of allergic diseases including allergic asthma, allergic rhinitis, and food allergies, with more than 550 whole allergens and allergen mixes, and 100 allergen components available.

EliA™ Autoimmune Tests

Broad, expanding portfolio of tests with excellent clinical performance designed to aid in the diagnosis of diseases such as celiac disease, connective tissue disease, and rheumatoid arthritis. 

Phadia Laboratory Systems 

Suite of fully automated systems designed for laboratories of all sizes to achieve operational efficiency and deliver accurate results that healthcare providers can trust.

These products may not be cleared for use in your country. Please contact your sales representative for information about specific product availability.
References
  1. Thermo Fisher Scientific. Data on File. 
  2. Crameri, R (2014). In vitro allergy diagnosis – allergen-specific IgE. In: Akdis, C A; Agache, I. EAACI Global Atlas of Allergy. Zurich: European Academy of Allergy and Clinical Immunology, 166-167.
Japan Modal Hidden Button